| scholarly article | Q13442814 |
| P2093 | author name string | Gaurav Patki | |
| Yuen-Sum Lau | |||
| P2860 | cites work | Parkinson-like syndrome induced by continuous MPTP infusion: convergent roles of the ubiquitin-proteasome system and alpha-synuclein | Q26269955 |
| Mitochondrial dysfunction and oxidative damage in parkin-deficient mice | Q28593859 | ||
| Chronic systemic pesticide exposure reproduces features of Parkinson's disease | Q29614763 | ||
| High levels of mitochondrial DNA deletions in substantia nigra neurons in aging and Parkinson disease | Q29619113 | ||
| Restorative effect of endurance exercise on behavioral deficits in the chronic mouse model of Parkinson's disease with severe neurodegeneration | Q33401101 | ||
| Mitochondrial dysfunction in the striatum of aged chronic mouse model of Parkinson's disease | Q33868426 | ||
| Molecular pathways involved in the neurotoxicity of 6-OHDA, dopamine and MPTP: contribution to the apoptotic theory in Parkinson's disease | Q33951094 | ||
| Age-related structural and functional changes of brain mitochondria. | Q34104048 | ||
| Chemical and physical properties and potential mechanisms: melatonin as a broad spectrum antioxidant and free radical scavenger. | Q34119022 | ||
| Neuroprotective effect of long-term NDI1 gene expression in a chronic mouse model of Parkinson disorder | Q34129621 | ||
| Human melatonin production decreases with age. | Q34190514 | ||
| Melatonin, mitochondria, and cellular bioenergetics | Q34196319 | ||
| The relationship between oxidative/nitrative stress and pathological inclusions in Alzheimer's and Parkinson's diseases | Q34679230 | ||
| Age-environment and gene-environment interactions in the pathogenesis of Parkinson's disease | Q34711976 | ||
| Neuroprotective effects and mechanisms of exercise in a chronic mouse model of Parkinson's disease with moderate neurodegeneration | Q34812895 | ||
| Bimodal circadian secretion of melatonin from the pineal gland in a living CBA mouse | Q35234949 | ||
| Progressive parkinsonism in mice with respiratory-chain-deficient dopamine neurons | Q35611727 | ||
| Mitochondrial dysfunction and age. | Q37035864 | ||
| Mitochondrial approaches for neuroprotection | Q37348590 | ||
| Physiological neuroprotection by melatonin in a 6-hydroxydopamine model of Parkinson's disease | Q40336587 | ||
| Acute and delayed effects of exercise on human melatonin secretion | Q41666358 | ||
| Mitochondrial complex I deficiency in Parkinson's disease | Q41821730 | ||
| Melatonin causes gene expression in aged animals to respond to inflammatory stimuli in a manner differing from that of young animals | Q43215392 | ||
| Melatonin treatment potentiates neurodegeneration in a rat rotenone Parkinson's disease model. | Q43291967 | ||
| Mouse model of Parkinsonism: a comparison between subacute MPTP and chronic MPTP/probenecid treatment | Q43759857 | ||
| Chronic administration of pharmacological levels of melatonin does not ameliorate the MPTP-induced degeneration of the nigrostriatal pathway | Q43807426 | ||
| Circadian rhythms of dopamine and dihydroxyphenyl acetic acid in the mouse striatum: effects of pinealectomy and of melatonin treatment | Q43933401 | ||
| Dopamine-dependent neurotoxicity of alpha-synuclein: a mechanism for selective neurodegeneration in Parkinson disease | Q44013447 | ||
| Effects of probenecid on striatal dopamine depletion in acute and long-term 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-treated mice | Q44198579 | ||
| Lysosomal malfunction accompanies alpha-synuclein aggregation in a progressive mouse model of Parkinson's disease | Q44212285 | ||
| Enhanced substantia nigra mitochondrial pathology in human alpha-synuclein transgenic mice after treatment with MPTP. | Q44802800 | ||
| Melatonin fails to protect against long-term MPTP-induced dopamine depletion in mouse striatum | Q44894630 | ||
| Does melatonin help save dopaminergic cells in MPTP-treated mice? | Q46365738 | ||
| Melatonin attenuates tyrosine hydroxylase loss and hypolocomotion in MPTP-lesioned rats | Q46449965 | ||
| MPTP treatment in mice does not transmit and cause Parkinsonian neurotoxicity in non-treated cagemates through close contact | Q46528858 | ||
| Low platelet mitochondrial complex I and complex II/III activity in early untreated Parkinson's disease | Q46691979 | ||
| Melatonin reduces the neuronal loss, downregulation of dopamine transporter, and upregulation of D2 receptor in rotenone-induced parkinsonian rats | Q46742263 | ||
| Early signs of neuronal apoptosis in the substantia nigra pars compacta of the progressive neurodegenerative mouse 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine/probenecid model of Parkinson's disease | Q46988233 | ||
| Diurnal rhythm in the central dopamine turnover in the rat | Q48174244 | ||
| The inflammatory reaction following 1-methyl-4-phenyl-1,2,3, 6-tetrahydropyridine intoxication in mouse | Q48245374 | ||
| Melatonin protects against rotenone-induced oxidative stress in a hemiparkinsonian rat model | Q48248905 | ||
| A novel mitochondrial 12SrRNA point mutation in parkinsonism, deafness, and neuropathy. | Q50493784 | ||
| A new motor test sensitive to aging and dopaminergic function. | Q52235808 | ||
| Aging and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced degeneration of dopaminergic neurons in the substantia nigra | Q68816621 | ||
| P433 | issue | 4 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Parkinson's disease | Q11085 |
| P304 | page(s) | 704-711 | |
| P577 | publication date | 2011-07-01 | |
| P1433 | published in | Pharmacology, Biochemistry and Behavior | Q15716554 |
| P1476 | title | Melatonin protects against neurobehavioral and mitochondrial deficits in a chronic mouse model of Parkinson's disease | |
| P478 | volume | 99 |
| Q41333290 | Anatomical and cellular localization of melatonin MT1 and MT2 receptors in the adult rat brain |
| Q35067144 | High aggression in rats is associated with elevated stress, anxiety-like behavior, and altered catecholamine content in the brain |
| Q35583125 | Impact of exercise on mitochondrial transcription factor expression and damage in the striatum of a chronic mouse model of Parkinson's disease |
| Q48160855 | Melatonin as a mitochondrial protector in neurodegenerative diseases |
| Q46557476 | Melatonin attenuates traumatic brain injury-induced inflammation: a possible role for mitophagy |
| Q48357495 | Melatonin enhances L-DOPA therapeutic effects, helps to reduce its dose, and protects dopaminergic neurons in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced Parkinsonism in mice |
| Q38834700 | Melatonin for Sleep Disorders in Patients with Neurodegenerative Diseases. |
| Q51721205 | Melatonin improves mitochondrial function in inguinal white adipose tissue of Zücker diabetic fatty rats. |
| Q42705031 | Melatonin inhibits manganese-induced motor dysfunction and neuronal loss in mice: involvement of oxidative stress and dopaminergic neurodegeneration |
| Q48271852 | Melatonin is protective against 6-hydroxydopamine-induced oxidative stress in a hemiparkinsonian rat model |
| Q48454930 | Melatonin prevents cell death and mitochondrial dysfunction via a SIRT1-dependent mechanism during ischemic-stroke in mice. |
| Q92404286 | Melatonin: Clinical Perspectives in Neurodegeneration |
| Q28075345 | Melatoninergic System in Parkinson's Disease: From Neuroprotection to the Management of Motor and Nonmotor Symptoms |
| Q38058550 | Mitochondria and chloroplasts as the original sites of melatonin synthesis: a hypothesis related to melatonin's primary function and evolution in eukaryotes. |
| Q26859141 | Mitochondria-Targeted Protective Compounds in Parkinson's and Alzheimer's Diseases |
| Q47980436 | Mitochondrial bioenergetics decay in aging: beneficial effect of melatonin |
| Q41363567 | Mitochondrial impairment and melatonin protection in parkinsonian mice do not depend of inducible or neuronal nitric oxide synthases |
| Q46290321 | Protective effects of melatonin against mitochondrial injury in a mouse model of multiple sclerosis |
| Q38359199 | Protective role of melatonin in mitochondrial dysfunction and related disorders |
| Q41312041 | Rapid Eye Movement Sleep Homeostatic Response: A Potential Marker for Early Detection of Parkinson's Disease |
| Q53407504 | Seipin deficiency in mice causes loss of dopaminergic neurons via aggregation and phosphorylation of α-synuclein and neuroinflammation. |
| Q27330088 | Sigma-1 receptor deficiency reduces MPTP-induced parkinsonism and death of dopaminergic neurons |
| Q38082744 | Study of antioxidative effects and anti-inflammatory effects in mice due to low-dose X-irradiation or radon inhalation |
| Q92300440 | The loss of dopaminergic neurons in DEC1 deficient mice potentially involves the decrease of PI3K/Akt/GSK3β signaling |
| Q87159811 | The yeast product Milmed enhances the effect of physical exercise on motor performance and dopamine neurochemistry recovery in MPTP-lesioned mice |
Search more.